Summary
Dr. Holden is the principal investigator of a newly funded $3.5M NIH award for a randomized controlled trial of Brain Safe, an intervention to reduce older adults' exposure to medications whose use is linked with dementia.
The project is a 5-year study funded by the National Institute on Aging of the National Institutes of Health (NIA/NIH). Joining Holden are co-investigators Malaz Boustani, Noll Campbell, Dan Clark, and Wanzhu Tu.
The Brain Safe app intervention is an extension of the team's work in the Brain Safety Lab, which includes publications on medication decision making and app feasibility and usability.
For more on the project, visit: https://www.regenstrief.org/article/will-app-help-patients-avoid-dementia-linked-drugs/